المؤلفون: Do, Quoc Dat, Hásková, Aneta, Radovnická, Lucie, Konečná, Judita, Horová, Eva, Parkin, Christopher G., Grunberger, George, Prázný, Martin, Šoupal, Jan

المصدر: Diabetes, Obesity & Metabolism; Jan2024, Vol. 26 Issue 1, p78-84, 7p

مصطلحات موضوعية: TYPE 1 diabetes, INSULIN, PEOPLE with diabetes, HYPOGLYCEMIA, GLYCOSYLATED hemoglobin, GLYCEMIC control

المؤلفون: Acciaroli, Giada¹, Parkin, Christopher G.² chris@cgparkin.org, Thomas, Roy¹, Layne, Jennifer¹, Norman, Gregory J.¹, Leone, Keri¹

المصدر: Diabetic Medicine. Jun2023, Vol. 40 Issue 6, p1-8. 8p.

مصطلحات موضوعية: *BLOOD sugar monitors, *SCIENTIFIC observation, *CLINICAL decision support systems, *BLOOD sugar monitoring, *GLYCEMIC control, *AGE distribution, *RETROSPECTIVE studies, *DESCRIPTIVE statistics, *RESEARCH funding

مصطلحات جغرافية: EUROPE

المؤلفون: Martens, Thomas W., Parkin, Christopher G.

المصدر: Postgraduate Medicine; Aug2022, Vol. 134 Issue 6, p576-588, 13p

مصطلحات موضوعية: TYPE 1 diabetes, GLYCOSYLATED hemoglobin, PRIMARY care, BLOOD sugar monitoring, GLUCOSE

المؤلفون: Galindo, Rodolfo J.^1,2,3 (AUTHOR), Parkin, Christopher G.⁴ (AUTHOR) chris@cgparkin.org, Aleppo, Grazia⁵ (AUTHOR), Carlson, Anders L.^6,7,8,9 (AUTHOR), Kruger, Davida F.¹⁰ (NURSE), Levy, Carol J.^11,12 (AUTHOR), Umpierrez, Guillermo E.^13,14 (AUTHOR), McGill, Janet B.¹⁵ (AUTHOR), Galindo, Rodolfo¹⁶ (AUTHOR), Carlson, Anders¹⁷ (AUTHOR), Kruger, Davida^18,19 (AUTHOR), Levy, Carol²⁰ (AUTHOR), Umpierrez, Guillermo²¹ (AUTHOR)

المصدر: Diabetes Technology & Therapeutics. Sep2021, Vol. 23 Issue 9, p652-660. 9p.

مصطلحات موضوعية: *TYPE 2 diabetes, *MEDICAID, *TYPE 1 diabetes, *CRITICAL currents, *MEDICARE, *GLUCOSE, *DIABETES, *BLOOD sugar monitoring, *BLOOD sugar, *INSURANCE

مصطلحات جغرافية: UNITED States

المؤلفون: Parkin, Christopher G, Holloway, Melissa, Truesdell, Jeffrey, C Walker, Tomas

مصطلحات موضوعية: Continuous Glucose Monitoring, demo, psy

العلاقة: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813469Test/

الإتاحة: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813469Test/

المؤلفون: Parkin, Christopher G.¹ chris@cgparkin.org, Homberg, Anita², Hinzmann, Rolf²

المصدر: Diabetes Technology & Therapeutics. Dec2018, Vol. 20 Issue 12, p857-880. 24p.

مصطلحات موضوعية: *BLOOD sugar monitoring, *PREDIABETIC state, *TYPE 1 diabetes, *TYPE 2 diabetes, *WEIGHT loss, *BLOOD sugar analysis, *COMPARATIVE studies, *CONFERENCES & conventions, *RESEARCH methodology, *MEDICAL cooperation, *RESEARCH, *EVALUATION research

مصطلحات جغرافية: NORWAY

المؤلفون: Parkin, Christopher G.¹, Homberg, Anita², Hinzmann, Rolf²

المصدر: Diabetes Technology & Therapeutics. Jan2018, Vol. 20 Issue 1, p68-89. 22p.

مصطلحات موضوعية: *BLOOD sugar monitoring, *TREATMENT of diabetes, *PEOPLE with diabetes, *CONFERENCES & conventions, *SOCIAL history

مصطلحات جغرافية: POLAND

المؤلفون: Aleppo, Grazia¹ (AUTHOR), Hirsch, Irl B.² (AUTHOR), Parkin, Christopher G.³ (AUTHOR) chris@cgparkin.org, McGill, Janet⁴ (AUTHOR), Galindo, Rodolfo⁵ (AUTHOR), Kruger, Davida F.⁶ (NURSE), Levy, Carol J.⁷ (AUTHOR), Forlenza, Gregory P.⁸ (AUTHOR), Umpierrez, Guillermo E.⁹ (AUTHOR), Grunberger, George¹⁰ (AUTHOR), Bergenstal, Richard M.¹¹ (AUTHOR)

المصدر: Diabetes Technology & Therapeutics. Oct2023, Vol. 25 Issue 10, p741-751. 11p.

مصطلحات موضوعية: *TYPE 2 diabetes, *TYPE 1 diabetes, *INSULIN therapy, *GLUCOSE, *ENDOCRINE diseases, *HYPERGLYCEMIA

الشركة/الكيان: AMERICAN Diabetes Association 784510570

المؤلفون: Parkin, Christopher G.¹, Homberg, Anita², Hinzmann, Rolf²

المصدر: Diabetes Technology & Therapeutics. Nov2016, Vol. 18 Issue 11, p727-747. 21p.

مصطلحات موضوعية: *TREATMENT of diabetes, *BLOOD sugar monitoring

المؤلفون: Puckrein, Gary A.¹ (AUTHOR), Hirsch, Irl B.² (AUTHOR), Parkin, Christopher G.³ (AUTHOR) chris@cgparkin.org, Taylor, Bruce T.⁴ (AUTHOR), Norman, Gregory J.⁴ (AUTHOR), Xu, Liou¹ (AUTHOR), Marrero, David G.⁵ (AUTHOR), Norman, Gregory⁶ (AUTHOR), Marerro, David G⁷ (AUTHOR)

المصدر: Diabetes Technology & Therapeutics. Jan2023, Vol. 25 Issue 1, p31-38. 8p.

مصطلحات موضوعية: *MEDICARE, *MEDICAID beneficiaries, *MEDICARE beneficiaries, *DISEASE risk factors, *BLOOD sugar monitoring, *INSULIN therapy, *GLUCOSE